The neurodegenerative disease market growth is charting an impressive trajectory as artificial intelligence and computational neuroscience converge to revolutionize drug discovery and development for complex brain disorders. Machine learning algorithms are now capable of predicting protein misfolding patterns, identifying novel drug targets from multi-omics datasets, and optimizing clinical...